Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update

Julia Lee
April 26, 2018

Market Update

Julia Lee
April 26, 2018

Equity Investor 23 April 2018

Bell Direct
April 24, 2018

Market Update

Julia Lee
April 18, 2018

Equity Investor 16 April

Julia Lee
April 17, 2018

Market Update

Julia Lee
April 12, 2018

LIC video – understand the basics

Bell Direct
April 11, 2018

Market Update

Julia Lee
April 6, 2018

Market Update

Julia Lee
March 26, 2018

Market Update

Julia Lee
March 23, 2018

Weekly Wrap 23 March

Julia Lee
March 23, 2018

Equity Investor 20 March

Julia Lee
March 20, 2018